Midostaurin is a drug used in the treatment of certain types of cancer. However, the manufacturing process of Midostaurin can result in the formation of impurities that can affect the safety and efficacy of the drug. These impurities can be organic or inorganic in nature and can vary in size and composition. Therefore, it is important to identify and control these impurities to ensure the quality of the drug product.
